Alfred E. Chang
Impact in
- Immunology top 0.05%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 0.05%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
Papers in
- Oncology 167
- CAR-T cell therapy research 73
- Cancer Immunotherapy and Biomarkers 45
- Cutaneous Melanoma Detection and Management 23
- Immunology 157
- Immunotherapy and Immune Responses 138
- Immune Cell Function and Interaction 59
- T-cell and B-cell Immunology 27
- Co-authors
- Steven A. Rosenberg (19 shared papers)Claudia A. Seipp (8 shared papers)Colleen Simpson (3 shared papers)Michael T. Lotze (6 shared papers)Susan F. Leitman (2 shared papers)Linda Muul (2 shared papers)Michael S. Sabel (46 shared papers)Seth M. Steinberg (9 shared papers)
- Journals
- Journal of Immunotherapy (26 papers)Annals of Surgical Oncology (22 papers)Cancer Research (18 papers)Journal of Surgical Oncology (16 papers)The Journal of Immunology (14 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Alfred E. Chang
297 papers receiving 21.2k citations
Alfred E. Chang's Hit Papers
Peers
Comparison fields: 5 of 171
- Immunology 9.3k
- Oncology 10.2k
- Hepatology 923
- Cancer Research 1.8k
- Pulmonary and Respiratory Medicine 3.2k
Countries citing papers authored by Alfred E. Chang
This map shows the geographic impact of Alfred E. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred E. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred E. Chang more than expected).
Fields of papers citing papers by Alfred E. Chang
This network shows the impact of papers produced by Alfred E. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred E. Chang. The network helps show where Alfred E. Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Alfred E. Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 305 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone Hit paper breakdown → | 1987 | 2351 |
| 2 | Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer Hit paper breakdown → | 1985 | 2148 |
| 3 | Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. Hit paper breakdown → | 1998 | 1202 |
| 4 | Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Hit paper breakdown → | 1993 | 773 |
| 5 | Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments Hit paper breakdown → | 2009 | 652 |
| 6 | A Prospective Randomized Trial of Regional Versus Systemic Continuous 5-Fluorodeoxyuridine Chemotherapy in the Treatment of Colorectal Liver Metastases Hit paper breakdown → | 1987 | 476 |
| 7 | 1988 | 383 | |
| 8 | 1998 | 373 | |
| 9 | 2002 | 370 | |
| 10 | 2007 | 349 | |
| 11 | Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. | 2001 | 279 |
| 12 | 2004 | 257 | |
| 13 | 1986 | 248 | |
| 14 | 2006 | 240 | |
| 15 | 2011 | 226 | |
| 16 | 1979 | 220 | |
| 17 | 1988 | 213 | |
| 18 | 1996 | 193 | |
| 19 | A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer. | 2002 | 193 |
| 20 | 2012 | 186 |
About Alfred E. Chang
Alfred E. Chang is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 305 papers that have together received 22.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (138 papers), CAR-T cell therapy research (73 papers), Immune Cell Function and Interaction (59 papers), Cancer Immunotherapy and Biomarkers (45 papers), T-cell and B-cell Immunology (27 papers), Cancer Research and Treatments (25 papers), Cutaneous Melanoma Detection and Management (23 papers) and Breast Cancer Treatment Studies (22 papers). The work is most often cited by research in Immunology (9.3k citations), Oncology (10.2k citations), Hepatology (923 citations), Cancer Research (1.8k citations) and Pulmonary and Respiratory Medicine (3.2k citations). Alfred E. Chang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Steven A. Rosenberg, Claudia A. Seipp, Colleen Simpson, Michael T. Lotze, Susan F. Leitman, Linda Muul, Michael S. Sabel, Seth M. Steinberg, Donald E. White and John T. Vetto. Their work appears in journals such as Journal of Immunotherapy, Annals of Surgical Oncology, Cancer Research, Journal of Surgical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.